When employed in the appropriate clinical circumstances and in conjunction with imaging findings, the markers of myocardial injury (cardiac troponins, I or T) and right ventricular dysfunction (BNP) are considered essential in the risk stratification of patients with pulmonary embolism. This evidence concerns the gene NPPB and pulmonary embolism.